Treatment of hyperproliferative conditions of body surfaces
AssigneeValderm ApS
InventorsBjarne Bymose, Thomas Broe Christensen
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical formulations comprising an anthracycline and the uses thereof for treatment of clinical conditions of body surfaces such as skin and mucosal membranes, wherein abnormal cell differentiation and/or hyperproliferation is a primary factor of the pathogenesis. In particular the invention relates to treatment of psoriasis, and preferably to treatment of psoriasis with valrubicin topically applied.
Claims9
A pharmaceutical composition comprising an lipophilic anthracycline together with one or more pharmaceutically acceptable carriers, wherein the lipophilic anthracycline is valrubicin, and
- wherein said pharmaceutical composition is formulated for topical administration to a body surface, and is selected from the group consisting of a lotion, an ointment, a gel, a cream, a transdermal patch;
- and a spray.
Dependencies are inferred from the claim text.